Biblio Discovery — Demo Discovery Service

14 results for "Burr, Adam"

Showing 1–14 · 0.27 seconds · RSS

  1. Journal Article Full text

    Patterns of failure for hypopharynx cancer patients treated with limited high-dose radiotherapy treatment volumes

    Burr, Adam; Harari, Paul; Wieland, Aaron et al.

    Radiat Oncol J · 2022 · English · PubMed Central

    PURPOSE: Optimal radiotherapy treatment volumes for patients with locally advanced hypopharynx squamous cell carcinoma should ensure maximal tumor coverage with minimal inclusion of normal surrounding structures. Here we evaluated the effectiveness of a direct 3-mm high-dose gross tumor volume to…

  2. Journal Article Full text

    Review of recent advances in managing periocular skin malignancies

    Trotier, Daniel C.; Huang, Leslie; van Landingham, Suzanne W. et al.

    Front Oncol · 2024 · English · PubMed Central

    Management of cutaneous malignancies can be particularly challenging when they are located in the periocular region. The standard of care for localized disease is complete surgical excision, but this may not be possible without significant disruption to visual structures and facial appearance…

  3. Journal Article Full text

    Combining Obinutuzumab With Radiation for Refractory DLBCL: Retrospective Safety and Efficacy Analysis

    Morris, Brett A.; Merfeld, Emily C.; Burr, Adam R. et al.

    Adv Radiat Oncol · 2024 · English · PubMed Central

    PURPOSE: Approximately 30% of patients with diffuse large B cell lymphoma (DLBCL) will develop relapsed or treatment-refractory disease after primary chemotherapy. Patients unable to undergo aggressive chemotherapy and stem cell transplant or chimeric antigen receptor T-cell (CAR T-cell) therapy…

  4. Journal Article Full text

    RADT-25. RECURRENT MENINGIOMAS REIRRADIATED WITH LARGE-VOLUME PULSED-REDUCED DOSE RATE RADIOTHERAPY: LONG-TERM SURVIVAL AND TOXICITY OUTCOMES

    Eckelmann, Bradley; Frenkel, Amy; Tome, Wolfgang et al.

    Neuro Oncol · 2025 · English · PubMed Central

    Meningiomas are the most common primary brain tumors in adults. Although local control is often achievable with surgical resection and radiation therapy, patients with recurrent disease treated with prior radiotherapy (RT) have few options for salvage treatment. We investigate retrospectively…

  5. Journal Article Full text

    CTNI-48. SURVIVAL, TOXICITY, AND PATIENT REPORTED QOL OUTCOMES FOLLOWING PULSED REDUCED DOSE RATE RE-IRRADIATION WITH CONCURRENT BEVACIZUMAB FOR RECURRENT GRADE 4 GLIOMAS: RESULTS OF A PHASE II STUDY

    Morris, Brett; Burr, Adam; Weiss, Marissa et al.

    Neuro Oncol · 2023 · English · PubMed Central

    Grade 4 gliomas are aggressive primary brain tumors with dismal prognosis despite maximal treatment. Recurrent disease is typically found within the prior radiation treatment field, complicating reirradiation. Pulsed reduced dose rate (PRDR) radiation is a treatment technique that reduces effective…

  6. Journal Article Full text

    Evaluation of a Novel Quantitative Multiparametric MR Sequence for Radiation Therapy Treatment Response Assessment

    Yan, Yuhao; Bayliss, R. Adam; Wiesinger, Florian et al.

    ArXiv · 2025 · English · PubMed Central

    BACKGROUND: Multi-parametric MRI has shown great promise to rapidly derive multiple quantitative imaging biomarkers for treatment response assessment. PURPOSE: To evaluate a novel Deep-Learning-enhanced MUlti-PArametric MR sequence (DL-MUPA) for treatment response assessment for brain metastases…

    Also available at: PubMed Central

  7. Journal Article Full text

    Pulsed reduced-dose rate re-irradiation for patients with recurrent grade 2 gliomas

    Harari, Colin M; Burr, Adam R; Morris, Brett A et al.

    Neurooncol Adv · 2024 · English · PubMed Central

    BACKGROUND: Patients with grade 2 glioma exhibit highly variable survival. Re-irradiation for recurrent disease has limited mature clinical data. We report treatment results of pulsed reduced-dose rate (PRDR) radiation for patients with recurrent grade 2 glioma. METHODS: A retrospective analysis of…

  8. Journal Article Full text

    Functional Outcomes After Transoral Plus Lateral Pharyngotomy Approach for Advanced Oral and Oropharyngeal Tumors

    Colevas, Sophia M.; Merfeld, Emily C.; Pflum, Zachary E. et al.

    OTO Open · 2023 · English · PubMed Central

    OBJECTIVE: The aim of this study was to evaluate our institutional experience with the combined transoral plus lateral pharyngotomy (TO+LP) approach in a subset of patients with advanced or recurrent oral and oropharyngeal malignancy. STUDY DESIGN: A retrospective study of procedures utilizing…

  9. Journal Article Full text

    Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients

    Flakus, Mattison J.; Kent, Sean P.; Wallat, Eric M. et al.

    Radiother Oncol · 2023 · English · PubMed Central

    PURPOSE: To identify metrics of radiation dose delivered to highly ventilated lung that are predictive of radiation-induced pneumonitis. METHODS AND MATERIALS: A cohort of 90 patients with locally advanced non-small cell lung cancer treated with standard fractionated radiation therapy (RT) (60-66…

  10. Journal Article Full text

    Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia

    Blitzer, Grace C.; Glazer, Tiffany; Burr, Adam et al.

    Cytotherapy · 2023 · English · PubMed Central

    BACKGROUND AIMS: Xerostomia, or the feeling of dry mouth, is a significant side effect of radiation therapy for head and neck cancer (HNC). Preliminary data suggests that mesenchymal stromal/stem cells (MSCs) can improve salivary function. We performed a first-in-human pilot study of interferon…

  11. Journal Article Full text

    Prospective study of PET/MRI tumor response during chemoradiotherapy for patients with low and intermediate-risk p16-positive oropharynx cancer

    Witek, Matthew E.; Kimple, Randall J.; Avey, Gregory D. et al.

    Am J Clin Oncol · 2022 · English · PubMed Central

    OBJECTIVES: To examine tumor response with PET/MRI during chemoradiotherapy as a predictor of outcome in patients with p16-positive oropharynx cancer. METHODS: Patients with p16-positive oropharynx cancer were treated with chemoradiotherapy. Low-risk (LR) disease was defined as T1–3 and N0–2b and ≤…

  12. Journal Article Full text

    Interstitial Brachytherapy for Lip Cancer: Technical Aspects to Individualize Treatment Approach and Optimize Outcomes

    Merfeld, Emily C; Witek, Matthew E; Francis, David M et al.

    Pract Radiat Oncol · 2023 · English · PubMed Central

    Primary radiotherapy using interstitial brachytherapy (IBT) provides excellent local tumor control for early-stage squamous cell carcinoma (SCC) of the lip. Technical aspects of treatment are important to optimize outcomes. In this report, we discuss patient selection criteria, procedural details…

  13. Journal Article Full text

    Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study

    Bruce, Justine Yang; Burr, Adam; Kimple, Randall J. et al.

    eBioMedicine · 2024 · English · PubMed Central

    BACKGROUND: Re-irradiation of recurrent head and neck cancer (HNC) is often limited by tumour adherence to critical structures and/or radiation tolerance of critical normal tissues. Iopofosine I 131 (CLR 131) is a targeted small molecular phospholipid ether (PLE) drug conjugate that delivers…